All Articles

“We made what I thought was a narcotic killer,” says Dr. Scott Martin of his biologically advanced CBD pain relief capsule, Preleve. Then Big Pharma shut him down.

The state health agency rejected autism as a qualifying condition last year. Now these mothers are fighting to reverse the decision.

Colorado’s governor rejected it as a medical marijuana condition, but a few states allow it. The science is promising, but not conclusive.

Among the amendments struck down en route to C-45’s passage: bans on home cultivation of cannabis and cannabis-branded merchandise.

Shamed into action by the suffering of an epileptic child whose only relief came from cannabis oil, law enforcement and health authorities in the United Kingdom will begin an “unprecedented” review of the country’s cannabis policy.

Smoke Cartel is one of the world’s leading online head shops. Meet the women helping bring quality glass to users around the world.

Trying to keep track of all the advances in cannabis research? Here are some brief summaries from some of the biggest headlines of the summer.

New York will take fewer marijuana smokers to police stations starting Sept. 1. Critics say it’s too little too late as the public clamors for bigger cannabis reforms.

The co-founder of the Canadian LP Indiva holds forth on unsung trailblazers, cannabis capitalists, and his legal obligation to be chaperoned by a “responsible person in charge” at his own damn company.

As the marijuana molecule cannabidiol nears FDA-approval, parents who for years have used cannabis to treat severe forms of epilepsy in their children are feeling more cautious than celebratory.